Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · IEX Real-Time Price · USD
2.340
-0.080 (-3.31%)
Jun 21, 2024, 4:00 PM EDT - Market closed

Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $145.43 million as of June 21, 2024. Its market cap has increased by 68.32% in one year.

Market Cap
145.43M
Enterprise Value
204.33M
1-Year Change
68.32%
Ranking
Category
Stock Price
$2.34

Market Cap Chart

Since September 9, 2002, Galectin Therapeutics's market cap has increased from $31.60M to $145.43M, an increase of 360.21%. That is a compound annual growth rate of 7.25%.

History

DateMarket Cap% Change
Jun 21, 2024145.40M-3.32%
Jun 20, 2024150.40M3.87%
Jun 18, 2024144.80M-6.82%
Jun 17, 2024155.40M-4.55%
Jun 14, 2024162.80M-1.51%
Jun 13, 2024165.30M-2.59%
Jun 12, 2024169.70M4.24%
Jun 11, 2024162.80M-3.33%
Jun 10, 2024168.40M4.21%
Jun 7, 2024161.60M-1.88%
Jun 6, 2024164.70M-3.29%
Jun 5, 2024170.30M-0.35%
Jun 4, 2024170.90M2.21%
Jun 3, 2024167.20M-1.07%
May 31, 2024169.00M-
May 30, 2024169.00M-2.54%
May 29, 2024173.40M-1.08%
May 28, 2024175.30M-7.54%
May 24, 2024189.60M-
May 23, 2024189.60M-1.91%
May 22, 2024193.30M-3.69%
May 21, 2024200.70M2.19%
May 20, 2024196.40M-2.14%
May 17, 2024200.70M2.87%
May 16, 2024195.10M2.58%
View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Repare Therapeutics 149.83M
Syros Pharmaceuticals 149.14M
Invivyd 147.95M
Gossamer Bio 147.04M
INmune Bio 146.59M
scPharmaceuticals 145.30M
Vigil Neuroscience 145.08M
Puma Biotechnology 144.23M
Market Cap Rankings